Stock BLUE BLUEBIRD BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.06 USD -5.36% Intraday chart for bluebird bio, Inc. +17.80% -23.19%
May. 09 Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 06 Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BLUEBIRD BIO, INC. Stock bluebird bio, Inc.
 204M - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. BLUE Stock
  4. Charts bluebird bio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW